KING ABDULAZIZ MEDICAL CITY
🇸🇩Sudan
The Prolonging Effect of Dexmedetomidine on Spinal Anesthesia Through Different Routes if Administrations
Phase 4
Not yet recruiting
- Conditions
- Spinal Anesthesia Evaluation
- Interventions
- Drug: Interventional group#1Drug: Interventional group#2
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 75
- Registration Number
- NCT06769737
- Locations
- 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
Completed
- Conditions
- Gestational Diabetes
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 247
- Registration Number
- NCT06109597
- Locations
- 🇸🇦
Fatimah Khobrani, Jeddah, Saudi Arabia
Nurse-led Pain Management in Adult ICU
Not Applicable
Completed
- Conditions
- Pain Management
- Interventions
- Other: Critical-Care Pain Observation Tool
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 880
- Registration Number
- NCT05488834
- Locations
- 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Silastic Sheet Usefulness Following Septoplasty
Not Applicable
Completed
- Conditions
- Septoplasty
- Interventions
- Procedure: Septoplasty surgery
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 50
- Registration Number
- NCT04921462
- Locations
- 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Injection Site Pain Botulinum Toxin Reconstituted in NS With and Without Sodium Bicarbonate
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 30
- Registration Number
- NCT04579419
- Locations
- 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4
- First Posted Date
- 2012-09-18
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 181
- Registration Number
- NCT01686789
- Locations
- 🇸🇦
King Khaled University Hospital, Riyadh, Saudi Arabia
🇸🇦King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
🇸🇦King Abdulaziz Medical City, Riyadh, Saudi Arabia
Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia
- Conditions
- AsthmaRhinitis
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2010-03-12
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 4000
- Registration Number
- NCT01085916
Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2010-02-02
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 102
- Registration Number
- NCT01060267
- Locations
- 🇸🇦
King Abdul Aziz Medical City, Riyadh 11426, Saudi Arabia
Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients
Phase 4
Completed
- Conditions
- Chronic Hepatitis CRenal Transplant
- Interventions
- Drug: Pegylated interferon alfa-2a plus ribavarin
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- King Abdulaziz Medical City
- Target Recruit Count
- 32
- Registration Number
- NCT00881582
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
🇸🇦Riyadh Military Hospital, Riyadh, Saudi Arabia
© Copyright 2025. All Rights Reserved by MedPath